Cleavage of the HIV-1 P66 Reverse Transcriptase/RNase H by the P9 Protease in Vitro Generates Active P15 RNase H
Overview
Authors
Affiliations
The reverse transcriptase/RNase H of HIV-1 is composed of a p66/p51 heterodimer when analyzed from virus particles. A recombinant reverse transcriptase (RT)/RNase H which after purification consisted mainly of p66 was analyzed as substrate of the purified recombinant HIV-1 protease p9 in vitro. The p66 protein if treated with the protease is processed to a stable p66/p51 heterodimer. A p15 protein is a prominent cleavage product which was identified as the carboxyterminal portion of p66 by means of a monoclonal antibody. It exhibits RNase H activity when tested by activated gel analysis. Presence of SDS during the incubation allowed complete degradation of p66 depending on the conditions, which indicates that conformation of a substrate is relevant for cleavage by the HIV-1 protease. A synthetic heptapeptide AET-FYVD derived from the region between RT and RNase H is cleaved efficiently in vitro by the HIV-1 protease at the F'Y junction, and may mimick a natural cleavage site. P66/p51 heterodimers exhibit higher RT and RNase H activities than p66 when renatured from polyacrylamide gels.
Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability.
London R Viruses. 2016; 8(10).
PMID: 27690082 PMC: 5086598. DOI: 10.3390/v8100260.
Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.
Slack R, Spiriti J, Ahn J, Parniak M, Zuckerman D, Ishima R Proteins. 2015; 83(8):1526-38.
PMID: 26061827 PMC: 4509971. DOI: 10.1002/prot.24843.
Boso G, Orvell C, Somia N J Virol. 2014; 89(2):1286-97.
PMID: 25392207 PMC: 4300642. DOI: 10.1128/JVI.02312-14.
The p66 immature precursor of HIV-1 reverse transcriptase.
Sharaf N, Poliner E, Slack R, Christen M, Byeon I, Parniak M Proteins. 2014; 82(10):2343-52.
PMID: 24771554 PMC: 4441793. DOI: 10.1002/prot.24594.
Szilvay A, Nornes S, Kannapiran A, Haukanes B, Endresen C, Helland D Arch Virol. 1993; 131(3-4):393-403.
PMID: 7688507 DOI: 10.1007/BF01378640.